Clearside Biomedical
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
LASEZKAY GEORGE M director, officer: CEO
Common Stock 3,330 N/A N/A
Purchase
WHITMORE BRADFORD T 10 percent owner
Common Stock 53,900 N/A N/A
Purchase
WHITMORE BRADFORD T 10 percent owner
Common Stock 62,000 N/A N/A
Purchase
WHITMORE BRADFORD T 10 percent owner
Common Stock 62,000 N/A N/A
Sale
LASEZKAY GEORGE M director, officer: CEO
Common Stock 13,411 N/A N/A
Purchase
HUMPHRIES WILLIAM D. director
Common Stock 5,586 N/A N/A
Purchase
WHITMORE BRADFORD T 10 percent owner
Common Stock 50,000 N/A N/A
Purchase
WHITMORE BRADFORD T 10 percent owner
Common Stock 300,000 N/A N/A
Sale
DEIGNAN CHARLES A. officer: Chief Financial Officer
Common Stock 14,992 N/A N/A
Purchase
HUTSON NANCY J director
Common Stock 5,000 N/A N/A
Sale
LASEZKAY GEORGE M director, officer: CEO
Common Stock 32,150 N/A N/A
Purchase
DEIGNAN CHARLES A. officer: Chief Financial Officer
Common Stock 7,500 N/A N/A
Purchase
LASEZKAY GEORGE M director, officer: CEO
Common Stock 12,000 N/A N/A
Purchase
DEIGNAN CHARLES A. officer: Chief Financial Officer
Common Stock 10,000 N/A N/A
Purchase
THORP CLAY director
Common Stock 8,000 N/A N/A
Option
CAGLE GERALD D. director
Common Stock 11,250 N/A N/A
Option
CAGLE GERALD D. director
Stock Option (right to buy) 8,618 N/A N/A
Option
CAGLE GERALD D. director
Common Stock 11,250 $8.96 $100,800
Purchase
WHITE DANIEL H. director, officer: President an..
Common Stock 11,000 N/A N/A
Sale
THORP CLAY director
Common Stock 61,139 N/A N/A
Sale
THORP CLAY director
Common Stock 100,000 N/A N/A
Option
CAGLE GERALD D. director
Stock Option (right to buy) 45,454 N/A N/A
Option
CAGLE GERALD D. director
Common Stock 45,454 N/A N/A
Sale
THORP CLAY director
Common Stock 5,231 N/A N/A
Purchase
DEIGNAN CHARLES A. officer: Chief Financial Officer
Common Stock 500 N/A N/A
Purchase
CAGLE GERALD D. director
Common Stock 7,500 N/A N/A
Sale
THORP CLAY director
Common Stock 33,630 N/A N/A
Sale
THORP CLAY director
Common Stock 100,000 N/A N/A
Sale
THORP CLAY director
Common Stock 5,000 $6.13 $30,650
Sale
THORP CLAY director
Common Stock 15,000 $6.09 $91,350
Sale
THORP CLAY director
Common Stock 15,000 $6.09 $91,350
Sale
THORP CLAY director
Common Stock 5,000 $6.99 $34,950
Sale
THORP CLAY director
Common Stock 15,000 $6.99 $104,850
Sale
THORP CLAY director
Common Stock 15,000 $6.99 $104,850
Sale
WHITE DANIEL H. director, officer: President an..
Common Stock 4,000 $7.81 $31,240
Sale
WHITE DANIEL H. director, officer: President an..
Common Stock 4,000 $7.81 $31,240
Sale
THORP CLAY director
Common Stock 6,000 $8.34 $50,040
Sale
THORP CLAY director
Common Stock 14,000 $8.59 $120,260
Sale
THORP CLAY director
Common Stock 15,000 $8.64 $129,600
Sale
THORP CLAY director
Common Stock 10,000 $7.54 $75,400
Sale
THORP CLAY director
Common Stock 6,000 $7.52 $45,120
Sale
THORP CLAY director
Common Stock 8,500 $7.49 $63,665
Sale
WHITE DANIEL H. director, officer: President an..
Common Stock 6,000 $7.63 $45,780
Sale
WHITE DANIEL H. director, officer: President an..
Common Stock 10,000 $7.53 $75,300
Purchase
SHAFFER CHRISTY L director
Common Stock 1,100 $7 $7,700
Purchase
DEIGNAN CHARLES A. officer: Chief Financial Officer
Common Stock 1,000 $7.07 $7,065
Purchase
CAGLE GERALD D. director
Common Stock 5,000 $7.08 $35,400
Sale
THORP CLAY director
Common Stock 15,000 $7.3 $109,500
Sale
THORP CLAY director
Common Stock 5,000 $7.98 $39,900
Sale
THORP CLAY director
Common Stock 4,500 $8.02 $36,090

Showing 50 to 100 of 147 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.